apollo
logo
0Login
Introducing Our Latest Arrival!
GOODNOCTO XR 6.25MG TABLET

GOODNOCTO XR 6.25MG TABLET

Consult Doctor
Not for online sale
Prescription drug
 Trailing icon

Composition

ZOLPIDEM-6.25MG

Manufacturer/Marketer

Lupin Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

About GOODNOCTO XR 6.25MG TABLET

GOODNOCTO XR 6.25MG TABLET belongs to a class of drugs called 'sedative-hypnotics' primarily used in the short-term treatment of insomnia. Insomnia is a disorder of sleep that causes difficulty in falling asleep or staying asleep. It may be acute (short-term) or chronic (long-term) in nature due to various complications like stress, anxiety, and breathing problems.

GOODNOCTO XR 6.25MG TABLET contains Zolpidem which works by increasing the activity of GABA, which is a chemical messenger in the brain acting as a natural nerve-calming agent, thereby inducing sleep. Thus, GOODNOCTO XR 6.25MG TABLET relaxes muscles, reduces anxiety, and helps to fall asleep.

Take GOODNOCTO XR 6.25MG TABLET as prescribed. Your doctor will advise you how often you take GOODNOCTO XR 6.25MG TABLET based on your medical condition. Some people may experience dizziness, diarrhoea, drowsiness, headache, nausea, vomiting, nose or throat infections, tiredness, stomach pain, double vision, and back pain. Most of these side effects of GOODNOCTO XR 6.25MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to GOODNOCTO XR 6.25MG TABLET or any other medicines, please tell your doctor. If you notice that the effect of tablets is not as well as at the beginning of the treatment, please consult a doctor as you might have developed tolerance to GOODNOCTO XR 6.25MG TABLET and dose adjustment may be required. If you are pregnant or breastfeeding, it is advised to consult a doctor before using GOODNOCTO XR 6.25MG TABLET. If you have kidney, liver, or breathing problems, severe muscle weakness, sleep apnoea (a serious condition where breathing stops and repeatedly starts in sleep), and if you have a history of depression or mental illness, please inform your doctor before taking GOODNOCTO XR 6.25MG TABLET.

Uses of GOODNOCTO XR 6.25MG TABLET

Insomnia (sleeplessness)

Medicinal Benefits

GOODNOCTO XR 6.25MG TABLET is a sleeping pill used in the short-term treatment of insomnia (difficulty in falling or staying asleep). GOODNOCTO XR 6.25MG TABLET increases the activity of GABA (a chemical messenger in brain that acts as natural nerve-calming agent) that is involved in inducing sleep. Thus, GOODNOCTO XR 6.25MG TABLET relaxes muscles, reduces anxiety and helps to fall asleep. Appropriate life style changes are recommended along with GOODNOCTO XR 6.25MG TABLET to improve the quality of sleep.

Directions for Use

Take GOODNOCTO XR 6.25MG TABLET on empty stomach for effective results or as advised by the doctor. Swallow it as a whole with a glass of water. Do not crush, chew or break it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of GOODNOCTO XR 6.25MG TABLET

  • Dizziness
  • Diarrhoea
  • Drowsiness
  • Headache
  • Nausea
  • Vomiting
  • Nose or throat infections
  • Tiredness
  • Stomach pain
  • Double vision
  • Back pain

Drug Warnings

If you notice that the tablets are not working as well as they did at the beginning of the treatment, please consult a doctor as you might have developed tolerance to GOODNOCTO XR 6.25MG TABLET and dose adjustment may be required. GOODNOCTO XR 6.25MG TABLET is a category C pregnancy drug and is not recommended for use during pregnancy as it may cause adverse effects on the baby after birth. If you are a breastfeeding mother, it is advised to consult a doctor before using GOODNOCTO XR 6.25MG TABLET. If you have kidney, liver, or breathing problems, severe muscle weakness, sleep apnoea (a severe condition in which breathing stops and starts repeatedly in sleep), and if you have a history of depression or mental illness, please inform your doctor before taking GOODNOCTO XR 6.25MG TABLET. Maintain a time gap of a minimum of 8 hours between taking GOODNOCTO XR 6.25MG TABLET and driving to reduce the risk of increased adverse effects.

Drug Interactions

Drug-Drug Interaction: GOODNOCTO XR 6.25MG TABLET may have interaction with high blood pressure-lowering medicines (metoprolol), opioid pain killers (hydrocodone, oxycodone, naloxone, tramadol), antidepressants (sertraline, desipramine, fluoxetine, venlafaxine, bupropion, fluvoxamine, escitalopram, amitriptyline, citalopram, duloxetine, mirtazapine), antibiotics (ciprofloxacin, rifampicin), antifungal drugs (ketoconazole), anti-anxiety drugs (alprazolam, clonazepam, lorazepam), antiallergics/antihistamines (diphenhydramine, hydroxyzine), muscle relaxants (cyclobenzaprine), and antiepileptic drugs (gabapentin, pregabalin).

Drug-Food Interaction: GOODNOCTO XR 6.25MG TABLET may interact with caffeine, St John’s wort (herbal medicine for treating depression), and may reduce the effectiveness of GOODNOCTO XR 6.25MG TABLET. Also, avoid alcohol intake as it may increase the risk of dependence, psychomotor impairment (slowdown of thought process and reduced physical movements), sleepwalking, or sleep-driving.

Drug-Disease Interaction: Do not take GOODNOCTO XR 6.25MG TABLET if you have severe liver disease, breathing problems, sleep apnoea (sudden stopping of breathing during sleep), severe muscle weakness, kidney problems, and any history of depression or mental illness.

Drug-Drug Interactions Checker List

  • METOPROLOL
  • OXYCODONE
  • NALOXONE
  • TRAMADOL
  • SERTRALINE
  • AMITRIPTYLINE
  • DIPHENHYDRAMINE
  • CITALOPRAM
  • CLONAZEPAM
  • DULOXETINE
  • FLUOXETINE
  • GABAPENTIN
  • HYDROXYZINE
  • ESCITALOPRAM
  • LORAZEPAM
  • PREGABALIN
  • MIRTAZAPINE
  • ALPRAZOLAM
  • CYCLOBENZAPRINE
  • HYDROCODONE

Habit Forming

Yes

Diet & Lifestyle Advise

  • Do regular exercise during day time.
  • Do not take nap during day time. Set regular timings to go to bed and wake up.
  • Relax yourself at least 1 hour before bedtime by taking a bath with warm water, listening to music or reading a book.
  • Make the bedroom dark and quiet and ensure that your pillows and mattresses are comfortable.
  • Avoid watching tv, using mobiles or laptops just before bedtime.
  • Limit caffeine intake including tea, coffee, hot chocolate, cola and energy drinks as it may reduce the effectiveness of GOODNOCTO XR 6.25MG TABLET.
  • Avoid consumption of alcohol as it may increase risk of psychomotor impairment (slowdown of thought process and reduced physical movements), dependence, sleep walking or sleep driving.

Special Advise

  • You are advised to take GOODNOCTO XR 6.25MG TABLET on empty stomach as taking GOODNOCTO XR 6.25MG TABLET with food may reduce the effect of GOODNOCTO XR 6.25MG TABLET.
  • If you are depressed or have had depression in the past, please inform your doctor before taking GOODNOCTO XR 6.25MG TABLET as it may increase self-harming or suicidal thoughts.
  • If you notice any behavioral side effects such as delusions (false belief), nightmares, irritability, restlessness, aggressiveness, or hallucinations (hear, feel or see things that are actually not present), please contact your doctor.
  • If you are allergic to any sugars, inform your doctor as GOODNOCTO XR 6.25MG TABLET contains lactose.

Disease/Condition Glossary

Insomnia: It is a disorder of sleep associated with problems in falling asleep or staying asleep. It may be acute (short-term) or chronic (long-term) in nature. Acute insomnia may last from one night to few weeks and occurs due to stress or changes in life. Chronic insomnia may last from more than 3 nights per week to more than 3 months. Insomnia is mostly caused due to depression, stress, anxiety, jet lag, shift work, uncomfortable beds, chronic illness, caffeine, nicotine or alcohol intake or due to certain medicines. It may be treated using sleeping pills, behaviour therapy, changes in sleep habits, identifying and treating chronic conditions.

Country of origin

India

Manufacturer/Marketer address

Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India Country of Origin: India
Other Info - GOO0078

FAQs

No, you are not recommended to take GOODNOCTO XR 6.25MG TABLET with hydrocodone or other opioid pain killers such as oxycodone, naloxone and tramadol as co-administration of these medicines with GOODNOCTO XR 6.25MG TABLET may increase the risk of difficulty in breathing, drowsiness, coma and even death. However, before using GOODNOCTO XR 6.25MG TABLET with any other medicines, you are advised to contact your doctor so that the dose may adjusted to use safely.
You are recommended to take GOODNOCTO XR 6.25MG TABLET just before bedtime as it helps to sleep quickly and improve the quality of sleep. If you forget to take GOODNOCTO XR 6.25MG TABLET at night, do not take it in the day time as it may cause drowsiness, confusion and dizziness.
No, GOODNOCTO XR 6.25MG TABLET is not recommended for depression patients as it may worsen the condition and increase self-harming or suicidal thoughts. Therefore, if you are suffering from depression or have history of depression, please inform your doctor before taking GOODNOCTO XR 6.25MG TABLET.
No, GOODNOCTO XR 6.25MG TABLET is not recommended for use during pregnancy especially in the third trimester and during delivery as it may cause adverse effects such as breathing problems, low body temperature, floppy muscle and withdrawal symptoms in baby after birth due to physical dependence.
Yes, GOODNOCTO XR 6.25MG TABLET may cause dependence (mental and physical effects caused due to compulsion of taking GOODNOCTO XR 6.25MG TABLET) if used in high doses and for prolonged time. This risk of dependency on GOODNOCTO XR 6.25MG TABLET increases in patients who have a history of drug or alcohol abuse.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Unsafe

Avoid consumption of alcohol with GOODNOCTO XR 6.25MG TABLET as it may increase the risk of dependence, psychomotor impairment (slowdown of thought process and reduced physical movements), sleep walking or sleep driving.

bannner image

Pregnancy

Unsafe

GOODNOCTO XR 6.25MG TABLET is a Category C pregnancy drug and is not recommended for use during pregnancy as it may cause adverse effects in baby after birth.

bannner image

Breast Feeding

Unsafe

Avoid breastfeeding while taking GOODNOCTO XR 6.25MG TABLET as it may be excreted in breast milk.

bannner image

Driving

Unsafe

You may experience dizziness, drowsiness, confusion, decreased alertness, blurred or double vision especially the day after taking GOODNOCTO XR 6.25MG TABLET. Therefore, avoid driving if you feel drowsy or dizzy after taking GOODNOCTO XR 6.25MG TABLET.

bannner image

Liver

Caution

Take GOODNOCTO XR 6.25MG TABLET with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required. GOODNOCTO XR 6.25MG TABLET is not recommended for severe liver disease patients.

bannner image

Kidney

Caution

Take GOODNOCTO XR 6.25MG TABLET with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.

bannner image

Children

Unsafe

GOODNOCTO XR 6.25MG TABLET is not recommended for children below 18 years of age.